We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication

Video   Jun 23, 2015

 

Currently, diagnosis of influenza is performed either through either polymerase chain reaction (PCR) or through rapid antigen detection assays. The rapid antigen detection assays currently available are highly specific but not very sensitive, and lack the ability to show if the strain of influenza detected is susceptible to antiviral agents, such as Tamiflu and Relenza. The ability to rapidly determine if a patient has an infectious disease and what type of treatment the infection will respond to, would significantly reduce the treatment decision time, shorten the impact of symptoms, and minimize transfer to others. In this study, a point-of-care style µPAD (microfluidic paper-based diagnostic) for influenza has been developed with the ability to determine antiviral susceptibility of the strain for treatment decision. The assay exploits the enzymatic activity of surface proteins present on all influenza strains, and potential false positive responses can be mitigated. A simple nasal swab sample diluted in water is added to the device, the sample is distributed to 4 different reagent zones, and development of the enzymatic substrate under different buffer conditions takes place on bottom of the device. Analysis can be performed by eye or through a colorimetric image analysis smartphone app.

 
 
 
 

Recommended Videos

How We're Using Dogs To Sniff Out Malaria

Video

What if we could diagnose some of the world's deadliest diseases by the smells our bodies give off? In a fascinating talk and live demo, biologist James Logan introduces Freya, a malaria-sniffing dog, to show how we can harness the awesome powers of animal scent to detect chemical signatures associated with infection – and change the way we diagnose disease.

WATCH NOW

Easily Automate High Content Screening Workflows

Video

This brief video shows step by step how PerkinElmer Signals™ Screening automates HCS workflows. Powered by TIBCO Spotfire®, Signals Screening provides an embedded app store for easy access to common software tools for curve fitting, image analysis, and much more. Handle big data for faster, more efficient drug discovery. Plus easily share and re-use your experiments.

WATCH NOW

A Cancer Campaign for the Lads| Rugby Star Raises Awareness

Video

Former Welsh rugby captain and testicular cancer survivor Matthew Rees urges men to "check their tackle."

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE